Approval · Notice of Compliance 23047 · 2019
XOSPATA: Notice of Compliance 23047
Issued December 23, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23047
- Date
- December 23, 2019
- Company
- Astellas Pharma Canada IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XOSPATA | 02495058 | Marketed |
Medicinal ingredients
- GILTERITINIB FUMARATE 40 MG per TAB